Lawrence G Raisz

Title: The Innovative Contributions of Lawrence G. Raisz

Introduction

Lawrence G. Raisz is a notable inventor based in Farmington, Connecticut. He has made significant contributions to the field of medicine, particularly in the treatment of hypercalcemia. His innovative approach has led to the development of a unique method that utilizes thionapthene-2-carboxylic acid (TNCA) and its pharmaceutically acceptable salts.

Latest Patents

Lawrence G. Raisz holds a patent for a method of treating malignancy-induced hypercalcemia. This treatment is effective even in tumor-bearing hosts before significant abnormal serum calcium levels occur. The patent outlines that the useful dosage of TNCA in humans ranges from about 1 to 60 mg/kg/day, with a preferred range of 2 to 30 mg/kg/day, and more preferably from 5 to 20 mg/kg/day. The oral administration of TNCA or its salts is highlighted as a clinically advantageous method for controlling or ameliorating hypercalcemia.

Career Highlights

Raisz is associated with Macrochem Corporation, where he continues to work on innovative solutions in the pharmaceutical field. His research and development efforts have contributed to advancements in medical treatments, particularly for conditions related to calcium imbalances in the body.

Collaborations

Lawrence G. Raisz has collaborated with Carlos M. Samour, working together to enhance the effectiveness of their research and development initiatives.

Conclusion

Lawrence G. Raisz's contributions to the field of medicine through his innovative patent for treating hypercalcemia demonstrate his commitment to improving patient care. His work continues to influence the pharmaceutical industry positively.